News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Nico Gagelmann Shares Article on How Remission Conversion Drives Outcomes After CAR T-cell Therapy for Multiple Myeloma
Nico Gagelmann
Jun 14, 2025, 18:04

Nico Gagelmann Shares Article on How Remission Conversion Drives Outcomes After CAR T-cell Therapy for Multiple Myeloma

Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X:

“Finally out
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma
Now in Blood Journals Portfolio
Timely for EHA2025″

Title: Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST

Authors: Maximilian Merz, Nico Gagelmann, Samih Smaili, Sarah Flossdorf, Sandra Sauer, Christof Scheid, Bastian von Tresckow, Gerald Georg Wulf, Katja C Weisel, Igor Blau, Monika Engelhardt, Ralph Wäsch, Natalie Schub, Raphael Teipel, Judith S. Hecker, Johannes M. Waldschmidt, Britta Besemer, Ben-Niklas Baermann, Simon Call, Leo Hansmann, Francis Ayuketang Ayuk, Marc S. Raab, Hermann Einsele, Uwe Platzbecker, Nicolaus Kröger

You can read the Full Article on Blood Journals Portfolio

Nico Gagelmann Shares Article on How Remission Conversion Drives Outcomes After CAR T-cell Therapy for Multiple Myeloma

More posts featuring Nico Gagelmann.

Bastian von Tresckow Ben-Niklas Baermann Britta Besemer cancer CAR T-cell therapy Christof Scheid Francis Ayuketang Ayuk Gerald Georg Wulf Hermann Einsele Igor Blau Johannes M Waldschmidt Judith S. Hecker Katja C. Weisel Leo Hansmann Marc S. Raab Maximilian Merz Monika Engelhardt multiple myeloma Natalie Schub Nico Gagelmann Nicolaus Kröger OncoDaily Oncology Ralph Wäsch Raphael Teipel Remission Conversion Samih Smaili Sandra Sauer Sarah Flossdorf Simon Call Uwe Platzbecker
Special Coverage
Blog
Jul 26, 2025, 14:58
Survivor Views Survey on Critical Issues by ACS CAN
Blog
Jul 26, 2025, 14:50
Julie Torode: Knowing Hepatitis Status is The First Step to Stopping Liver Cancer
Insight
Jul 26, 2025, 14:17
How TAF1 Molecule Regulates Hematopoiesis - Sylvester Comprehensive Cancer Center
Blog
Jul 26, 2025, 14:12
Alfonso Martinez Arias: How to Use Granuloids in Transcriptional Regulation of Gene Expression
Blog
Jul 26, 2025, 13:46
The Updated Oncology Medical Home Standards are Now Available - ASCO
Career
Jul 26, 2025, 13:35
Stephanie A Haddad։ Excited to Accept the Lynn Sage Breast Cancer Symposium Travel Award
Blog
Jul 26, 2025, 13:34
Volunteer Opportunities at Medicaid Cancer Foundation
Insight
Jul 26, 2025, 13:25
Sibylle Loibl: Outcomes of Targeted Axillary Surgery
Insight
Jul 26, 2025, 13:19
Runcie Chidebe: The Educational and Practice Needs of Oncology Pharmacists in Nigeria and West Africa
Blog
Jul 26, 2025, 13:07
Path to Better Treatments for Osteosarcoma - St. Baldrick's Foundation
Blog
Jul 26, 2025, 12:58
Matteo Lambertini: The Super ESMO Course in Medical Oncology for Medical Students had Officially Started
Blog
Jul 26, 2025, 12:57
Phuong Ly-Gallagher: Updating My Profile to 18 Year Survivor Instead of 17 Years